“…Current barriers to improving CVD prevention and management, and thus life expectancy, include but are not limited to: a lack of standardized data on race/ethnicity and other minoritized populations, as well as structural and institutional racism and implicit biases that have led to incongruent treatment of certain populations [15,16]; lack of access to affordable and adequate health insurance and health care [17]; a failure to translate new evidence and innovations into practice in a timely manner [3,5]; insufficient funding for clinical trials that focus on common chronic diseases including CVD [1,4,10]; anemic data-sharing practices across the health care ecosystem [18]; insufficient digital health equity and literacy; and a disjointed public health infrastructure. Improvements are also stymied by a flawed medical care payment and delivery system that rewards volume over value, focuses more on sickness than health, leads to significant fragmentation and higher costs without the corresponding outcomes to show for it, and is not personcentered, equitable, or efficient [10,19,20].…”